Passive antibody therapy for infectious diseases

Arturo Casadevall, Ekaterina Dadachova, Liise Anne Pirofski

Research output: Contribution to journalArticle

Abstract

Antibody-based therapies are currently undergoing a renaissance. After being developed and then largely abandoned in the twentieth century, many antibody preparations are now in clinical use. However, most of the reagents that are available target non-infectious diseases. Interest in using antibodies to treat infectious diseases is now being fuelled by the wide dissemination of drug-resistant microorganisms, the emergence of new microorganisms, the relative inefficacy of antimicrobial drugs in immunocompromised hosts and the fact that antibody-based therapies are the only means to provide immediate immunity against biological weapons. Given the need for new antimicrobial therapies and many recent technological advances in the field of immunoglobulin research, there is considerable optimism regarding renewed applications of antibody-based therapy for the prevention and treatment of infectious diseases.

Original languageEnglish (US)
Pages (from-to)695-703
Number of pages9
JournalNature Reviews Microbiology
Volume2
Issue number9
DOIs
StatePublished - Sep 2004
Externally publishedYes

Fingerprint

Communicable Diseases
Antibodies
Biological Warfare Agents
Therapeutics
Immunocompromised Host
Pharmaceutical Preparations
Immunoglobulins
Immunity
Research

ASJC Scopus subject areas

  • Microbiology

Cite this

Passive antibody therapy for infectious diseases. / Casadevall, Arturo; Dadachova, Ekaterina; Pirofski, Liise Anne.

In: Nature Reviews Microbiology, Vol. 2, No. 9, 09.2004, p. 695-703.

Research output: Contribution to journalArticle

Casadevall, Arturo ; Dadachova, Ekaterina ; Pirofski, Liise Anne. / Passive antibody therapy for infectious diseases. In: Nature Reviews Microbiology. 2004 ; Vol. 2, No. 9. pp. 695-703.
@article{d4ce6c2c2e4b41859d91c13c110a5727,
title = "Passive antibody therapy for infectious diseases",
abstract = "Antibody-based therapies are currently undergoing a renaissance. After being developed and then largely abandoned in the twentieth century, many antibody preparations are now in clinical use. However, most of the reagents that are available target non-infectious diseases. Interest in using antibodies to treat infectious diseases is now being fuelled by the wide dissemination of drug-resistant microorganisms, the emergence of new microorganisms, the relative inefficacy of antimicrobial drugs in immunocompromised hosts and the fact that antibody-based therapies are the only means to provide immediate immunity against biological weapons. Given the need for new antimicrobial therapies and many recent technological advances in the field of immunoglobulin research, there is considerable optimism regarding renewed applications of antibody-based therapy for the prevention and treatment of infectious diseases.",
author = "Arturo Casadevall and Ekaterina Dadachova and Pirofski, {Liise Anne}",
year = "2004",
month = "9",
doi = "10.1038/nrmicro974",
language = "English (US)",
volume = "2",
pages = "695--703",
journal = "Nature Reviews Microbiology",
issn = "1740-1526",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Passive antibody therapy for infectious diseases

AU - Casadevall, Arturo

AU - Dadachova, Ekaterina

AU - Pirofski, Liise Anne

PY - 2004/9

Y1 - 2004/9

N2 - Antibody-based therapies are currently undergoing a renaissance. After being developed and then largely abandoned in the twentieth century, many antibody preparations are now in clinical use. However, most of the reagents that are available target non-infectious diseases. Interest in using antibodies to treat infectious diseases is now being fuelled by the wide dissemination of drug-resistant microorganisms, the emergence of new microorganisms, the relative inefficacy of antimicrobial drugs in immunocompromised hosts and the fact that antibody-based therapies are the only means to provide immediate immunity against biological weapons. Given the need for new antimicrobial therapies and many recent technological advances in the field of immunoglobulin research, there is considerable optimism regarding renewed applications of antibody-based therapy for the prevention and treatment of infectious diseases.

AB - Antibody-based therapies are currently undergoing a renaissance. After being developed and then largely abandoned in the twentieth century, many antibody preparations are now in clinical use. However, most of the reagents that are available target non-infectious diseases. Interest in using antibodies to treat infectious diseases is now being fuelled by the wide dissemination of drug-resistant microorganisms, the emergence of new microorganisms, the relative inefficacy of antimicrobial drugs in immunocompromised hosts and the fact that antibody-based therapies are the only means to provide immediate immunity against biological weapons. Given the need for new antimicrobial therapies and many recent technological advances in the field of immunoglobulin research, there is considerable optimism regarding renewed applications of antibody-based therapy for the prevention and treatment of infectious diseases.

UR - http://www.scopus.com/inward/record.url?scp=4444342539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444342539&partnerID=8YFLogxK

U2 - 10.1038/nrmicro974

DO - 10.1038/nrmicro974

M3 - Article

C2 - 15372080

AN - SCOPUS:4444342539

VL - 2

SP - 695

EP - 703

JO - Nature Reviews Microbiology

JF - Nature Reviews Microbiology

SN - 1740-1526

IS - 9

ER -